eqx announ and report ..

I hold EQX and am very positive about this stock. This is only one of two (other one being CCE) biotechnology stocks left in my portfolio. Here is part of today's announc:

Gingerol Project
Milestone 1 activities on the Gingerol Project continued during the September Quarter, with pharmacological studies commencing on lead compounds supplied to date. The synthesis and supply of the remaining compounds is nearing completion. Contracts for
the pharmacology activities to be undertaken during the Milestone have been let to the Centre for Pharmaceutical Research, University of South Australia and to the Pain Management Research Institute, Northern Clinical School, Faculty of Medicine at the
University of Sydney.

Vaccine Technology
As reported in the June Quarterly report, EQiTX has been granted exclusive rights by the Cooperative Research Centre for Vaccine Technology to finalise negotiations to acquire a family of patents to develop human therapeutic and prophylactic vaccines. Negotiations to finalise the acquisition of this opportunity are at an advanced stage.


I will appreciate any comments. Thanks



Please do your own research. I am here to learn.